APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peripheral Neuritis Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peripheral Neuritis Treatment Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchPeripheral Neuritis Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Peripheral Neuritis Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Peripheral Neuritis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peripheral Neuritis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Peripheral Neuritis Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Peripheral Neuritis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peripheral Neuritis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Peripheral Neuritis Treatment market include Teva Pharmaceuticals, Sanofi, Johnson & Johnson, Novartis, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Biogen and Baxter Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peripheral Neuritis Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peripheral Neuritis Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peripheral Neuritis Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peripheral Neuritis Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Peripheral Neuritis Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peripheral Neuritis Treatment Market by Company

Teva Pharmaceuticals

Sanofi

Johnson & Johnson

Novartis

Eli Lilly and Company

Pfizer

GlaxoSmithKline

Biogen

Baxter Healthcare

Depomed

Bristol-Myers Squibb

Peripheral Neuritis Treatment Segment by Type

Idiopathic Peripheral Neuropathy (IPN)

Diabetic Peripheral Neuropathy (DPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Others

Peripheral Neuritis Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Peripheral Neuritis Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peripheral Neuritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peripheral Neuritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peripheral Neuritis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Peripheral Neuritis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Peripheral Neuritis Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Peripheral Neuritis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Peripheral Neuritis Treatment Market Share by Region (2021-2026) Table 4. Global Peripheral Neuritis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Peripheral Neuritis Treatment Market Share by Region (2027-2032) Table 6. Global Peripheral Neuritis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Peripheral Neuritis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Peripheral Neuritis Treatment Market Size Share by Type (2021-2026) Table 9. Global Peripheral Neuritis Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Peripheral Neuritis Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Peripheral Neuritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Peripheral Neuritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Peripheral Neuritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Peripheral Neuritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Peripheral Neuritis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Peripheral Neuritis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Peripheral Neuritis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Peripheral Neuritis Treatment Market Size Share by Application (2021-2026) Table 24. Global Peripheral Neuritis Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Peripheral Neuritis Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Peripheral Neuritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Peripheral Neuritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Peripheral Neuritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Peripheral Neuritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Peripheral Neuritis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Peripheral Neuritis Treatment Industry Trends Table 37. Peripheral Neuritis Treatment Industry Drivers Table 38. Peripheral Neuritis Treatment Industry Opportunities and Challenges Table 39. Peripheral Neuritis Treatment Industry Restraints Table 40. Global Peripheral Neuritis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Peripheral Neuritis Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Peripheral Neuritis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Peripheral Neuritis Treatment Key Company Headquarters & Area Served Table 44. Global Peripheral Neuritis Treatment Company, Product Type & Application Table 45. Global Peripheral Neuritis Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Peripheral Neuritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Pharmaceuticals Company Information Table 49. Teva Pharmaceuticals Business Overview Table 50. Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Pharmaceuticals Peripheral Neuritis Treatment Product Portfolio Table 52. Teva Pharmaceuticals Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Peripheral Neuritis Treatment Product Portfolio Table 57. Sanofi Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Peripheral Neuritis Treatment Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Peripheral Neuritis Treatment Product Portfolio Table 67. Novartis Recent Development Table 68. Eli Lilly and Company Company Information Table 69. Eli Lilly and Company Business Overview Table 70. Eli Lilly and Company Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Eli Lilly and Company Peripheral Neuritis Treatment Product Portfolio Table 72. Eli Lilly and Company Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Peripheral Neuritis Treatment Product Portfolio Table 77. Pfizer Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Peripheral Neuritis Treatment Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Biogen Company Information Table 84. Biogen Business Overview Table 85. Biogen Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biogen Peripheral Neuritis Treatment Product Portfolio Table 87. Biogen Recent Development Table 88. Baxter Healthcare Company Information Table 89. Baxter Healthcare Business Overview Table 90. Baxter Healthcare Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Baxter Healthcare Peripheral Neuritis Treatment Product Portfolio Table 92. Baxter Healthcare Recent Development Table 93. Depomed Company Information Table 94. Depomed Business Overview Table 95. Depomed Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Depomed Peripheral Neuritis Treatment Product Portfolio Table 97. Depomed Recent Development Table 98. Bristol-Myers Squibb Company Information Table 99. Bristol-Myers Squibb Business Overview Table 100. Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bristol-Myers Squibb Peripheral Neuritis Treatment Product Portfolio Table 102. Bristol-Myers Squibb Recent Development Table 103. North America Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Peripheral Neuritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Peripheral Neuritis Treatment Market Share by Country (2021-2026) Table 106. North America Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Peripheral Neuritis Treatment Market Share Forecast by Country (2027-2032) Table 108. Europe Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Peripheral Neuritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Peripheral Neuritis Treatment Market Share by Country (2021-2026) Table 111. Europe Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Peripheral Neuritis Treatment Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Peripheral Neuritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Peripheral Neuritis Treatment Market Share by Country (2021-2026) Table 116. Asia-Pacific Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Peripheral Neuritis Treatment Market Share Forecast by Country (2027-2032) Table 118. Latin America Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Peripheral Neuritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Peripheral Neuritis Treatment Market Share by Country (2021-2026) Table 121. Latin America Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Peripheral Neuritis Treatment Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Peripheral Neuritis Treatment Market Share by Country (2021-2026) Table 126. Middle East & Africa Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Peripheral Neuritis Treatment Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Peripheral Neuritis Treatment Product Image Figure 3. Global Peripheral Neuritis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Peripheral Neuritis Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Peripheral Neuritis Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Peripheral Neuritis Treatment Market Share by Region (2021-2032) Figure 7. North America Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Idiopathic Peripheral Neuropathy (IPN) Image Figure 13. Global Idiopathic Peripheral Neuropathy (IPN) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Diabetic Peripheral Neuropathy (DPN) Image Figure 15. Global Diabetic Peripheral Neuropathy (DPN) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Chemotherapy-induced Peripheral Neuropathy (CIPN) Image Figure 17. Global Chemotherapy-induced Peripheral Neuropathy (CIPN) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Peripheral Neuritis Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Peripheral Neuritis Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Peripheral Neuritis Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Peripheral Neuritis Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Peripheral Neuritis Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Peripheral Neuritis Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Peripheral Neuritis Treatment Market Size Share by Type (2021-2032) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Peripheral Neuritis Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Peripheral Neuritis Treatment Market Share by Application 2025 VS 2032 Figure 35. North America Peripheral Neuritis Treatment Market Size Share by Application (2021-2032) Figure 36. Europe Peripheral Neuritis Treatment Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Peripheral Neuritis Treatment Market Size Share by Application (2021-2032) Figure 38. Latin America Peripheral Neuritis Treatment Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Peripheral Neuritis Treatment Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Peripheral Neuritis Treatment Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Peripheral Neuritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Peripheral Neuritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 45. Europe Peripheral Neuritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Peripheral Neuritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 48. Asia-Pacific Peripheral Neuritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Peripheral Neuritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 51. Latin America Peripheral Neuritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Peripheral Neuritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 54. Middle East & Africa Peripheral Neuritis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Peripheral Neuritis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Peripheral Neuritis Treatment Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Idiopathic Peripheral Neuropathy (IPN)
  • Diabetic Peripheral Neuropathy (DPN)
  • Chemotherapy-induced Peripheral Neuropathy (CIPN)
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Baxter Healthcare
  • Depomed
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Peripheral Neuritis Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Peripheral Neuritis Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Peripheral Neuritis Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Peripheral Neuritis Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Peripheral Neuritis Treatment Market Size (2021-2032)
  8. 1.5.1 North America Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Peripheral Neuritis Treatment Market Size Growth Rate (2021-2032)
2 Peripheral Neuritis Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Idiopathic Peripheral Neuropathy (IPN)
  3. 2.1.2 Diabetic Peripheral Neuropathy (DPN)
  4. 2.1.3 Chemotherapy-induced Peripheral Neuropathy (CIPN)
  5. 2.1.4 Others
  6. 2.2 Global Peripheral Neuritis Treatment Market Size by Type
  7. 2.2.1 Global Peripheral Neuritis Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Peripheral Neuritis Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Peripheral Neuritis Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Peripheral Neuritis Treatment Market Size by Regions
  11. 2.3.1 North America Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Peripheral Neuritis Treatment Market Size Breakdown by Type (2021-2026)
3 Peripheral Neuritis Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Peripheral Neuritis Treatment Market Size by Application
  6. 3.2.1 Global Peripheral Neuritis Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Peripheral Neuritis Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Peripheral Neuritis Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Peripheral Neuritis Treatment Market Size by Regions
  10. 3.3.1 North America Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Peripheral Neuritis Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Peripheral Neuritis Treatment Industry Trends
  2. 4.2 Peripheral Neuritis Treatment Industry Drivers
  3. 4.3 Peripheral Neuritis Treatment Industry Opportunities and Challenges
  4. 4.4 Peripheral Neuritis Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Peripheral Neuritis Treatment Revenue (2021-2026)
  2. 5.2 Global Peripheral Neuritis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Peripheral Neuritis Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Peripheral Neuritis Treatment Company, Product Type & Application
  5. 5.5 Global Peripheral Neuritis Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Peripheral Neuritis Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Peripheral Neuritis Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Peripheral Neuritis Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Peripheral Neuritis Treatment Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Peripheral Neuritis Treatment Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Peripheral Neuritis Treatment Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Peripheral Neuritis Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Eli Lilly and Company
  26. 6.5.1 Eli Lilly and Company Company Information
  27. 6.5.2 Eli Lilly and Company Business Overview
  28. 6.5.3 Eli Lilly and Company Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly and Company Peripheral Neuritis Treatment Product Portfolio
  30. 6.5.5 Eli Lilly and Company Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Peripheral Neuritis Treatment Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Peripheral Neuritis Treatment Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biogen Peripheral Neuritis Treatment Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 Baxter Healthcare
  50. 6.9.1 Baxter Healthcare Company Information
  51. 6.9.2 Baxter Healthcare Business Overview
  52. 6.9.3 Baxter Healthcare Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Baxter Healthcare Peripheral Neuritis Treatment Product Portfolio
  54. 6.9.5 Baxter Healthcare Recent Developments
  55. 6.10 Depomed
  56. 6.10.1 Depomed Company Information
  57. 6.10.2 Depomed Business Overview
  58. 6.10.3 Depomed Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Depomed Peripheral Neuritis Treatment Product Portfolio
  60. 6.10.5 Depomed Recent Developments
  61. 6.11 Bristol-Myers Squibb
  62. 6.11.1 Bristol-Myers Squibb Company Information
  63. 6.11.2 Bristol-Myers Squibb Business Overview
  64. 6.11.3 Bristol-Myers Squibb Peripheral Neuritis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb Peripheral Neuritis Treatment Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Recent Developments
7 North America
  1. 7.1 North America Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Peripheral Neuritis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Peripheral Neuritis Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst